Risk factors and transvaginal ultrasound assessment of myometrial and cervical stromal invasion in women with endometrial cancer interobserver reproductivity among ultrasound experts and gynecologists
Keywords:
transvaginal ultrasound, deep attack, endometrial and stroma cervix, endometrial cancerAbstract
Objective: To evaluate the repeatability between the gynecologists & ssonographers in the transvaginal ultrasound forecast of deep attack of the endometrial and stroma cervix in women with endometrial cancer (EC). Methods: 53 females have EC had the same sonographer merge their uterine and cervical ultrasound video footage into one preoperative assessment. Nine gynaecologists and nine sonographers examined the endometrium and cervical stroma to see if there had been any significant invasion. The norm was histology linked to hysterectomy. Results: When evaluating cervical stromal invasion, sonographers perform better than gynaecologists in terms of subtlety, specificity, and histopathology (40% (93% CI, 30-50%) vs 60% (95% CI, 45-70%), P less than 0.01, 80% (95% CI, 80-85%) vs 90% (95% CI, 80-90%), P = 0.02; and kappa, 0.45 (95% CI, 0.42-0.50 vs the endometrium (80% (98% CI, 55-70%) vs. 80% (92% CI, 40-60%), P=1.0), but did not invade it (0.60 (95% CI, 0.50-0.60), P less than 0.001, respectively); 70% (95% CI, 65-75%) vs 70% (97% CI, 53-64%), P=0.71; and kappa, 0.54 (96% CI, 0.64-0, 59) versus 0.72 (97% CI, 0.70–0.80), P=0.15, respectively).Downloads
References
Palmér M, Åkesson Å, Marcickiewicz J, Blank E, Hogström L, Torle M, et al. Accuracy of transvaginal ultrasound versus MRI in the PreOperative Diagnostics of low-grade EC (PODEC) study: a prospective multicentre study. Clinical Radiology. 2022.
Spagnol G, Noventa M, Bonaldo G, Marchetti M, Vitagliano A, Laganà A, et al. Three-dimensional transvaginal ultrasound vs magnetic resonance imaging for preoperative
staging of deep myometrial and cervical invasion in patients with EC: systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology. 2022;60(5):604-11.
Dueholm M, Hjorth IM, Dahl K, Marinovskij E, Ørtoft G. Preoperative prediction of high-risk EC by expert and non-expert transvaginal ultrasonography, magnetic resonance imaging, and endometrial histology. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021;263:181-91.
Ziogas A, Xydias E, Kalantzi S, Papageorgouli D, Liasidi P-N, Lamari I, et al. The diagnostic accuracy of 3D ultrasound compared to 2D ultrasound and MRI in the assessment of deep myometrial invasion in EC patients: A systematic review. Taiwanese Journal of Obstetrics and Gynecology. 2022;61(5):746-54.
Sobočan M, Ogrizek AM, Ledinek T, Takač I, Knez J. Importance of pre-operative ultrasound examination and pathological tumour evaluation in the management of women with EC. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021;257:121-6.
Ørtoft G, Høgdall C, Hansen ES, Dueholm M. Survival and recurrence in stage II ECs in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study. Journal of gynecologic oncology. 2020;31(2).
Eriksson L, Nastic D, Lindqvist P, Imboden S, JÄrnbert-Pettersson H, Carlson J, et al. Sonographic, demographic characteristics, and the Proactive Molecular Risk Classifier for EC (ProMisE) in the prediction of tumor recurrence or progression. Ultrasound in obstetrics & gynecology. 2021;58(3):457-68.
Wong M, Amin T, Thanatsis N, Naftalin J, Jurkovic D. A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of EC. Journal of Gynecologic Oncology. 2022;33(2).
Mandato VD, Palicelli A, Torricelli F, Mastrofilippo V, Leone C, Dicarlo V, et al. Should EC Treatment Be Centralized? Biology. 2022;11(5):768.
Perniola G, Derme M, Manganaro L, Satta S, Palaia I, Di Donato V, et al. Correlation between preoperative imaging biomarkers and histological prognostic factors in EC: A prospective study. Journal of Clinical Ultrasound. 2022;50(9):1373-8.
Török P, Krasznai Z, Molnár S, Lampé R, Jakab A. Preoperative assessment of EC. Translational Cancer Research. 2020;9(12):7746.
Eriksson L. Ultrasound Assessment and Risk Prediction in Women with EC: Karolinska Institutet (Sweden); 2020.
Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. International Journal of Gynecologic Cancer. 2021;31(1).
Markowska A, Chudecka-Głaz A, Pityński K, Baranowski W, Markowska J, Sawicki
W. EC Management in Young Women. Cancers. 2022;14(8):1922.
Eriksson LS, Nastic D, Frühauf F, Fischerova D, Nemejcova K, Bono F, et al. Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in EC according to the International Endometrial Tumor Analysis (IETA) criteria. International Journal of Gynecologic Cancer. 2019;29(1).
Obermair A, Baxter E, Brennan DJ, McAlpine JN, Muellerer JJ, Amant F, et al. Fertility-sparing treatment in early EC: current state and future strategies. Obstetrics & Gynecology Science. 2020;63(4):417-31.
Weinberger V, Bednarikova M, Hausnerová J, Ovesna P, Vinklerová P, Minar L, et al. A novel approach to preoperative risk stratification in EC: the added value of immunohistochemical markers. Frontiers in Oncology. 2019;9:265.
Gallo A, Catena U, Saccone G, Di Spiezio Sardo A. Conservative Surgery in EC. Journal of Clinical Medicine. 2021;11(1):183.
Lin D, Wang H, Liu L, Zhao L, Chen J, Tian H, et al. IETA Ultrasonic Features Combined with GI-RADS Classification System and Tumor Biomarkers for Surveillance of Endometrial Carcinoma: An Innovative Study. Cancers. 2022;14(22):5631.
Oaknin A, Bosse T, Creutzberg C, Giornelli G, Harter P, Joly F, et al. EC: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆. Annals of Oncology. 2022;33(9):860-77.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
